Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHOLDEPS: Choline Alphoscerate for Older Adults With MDD and Subjective Memory Complaints
NCT05257902Phase 4Completed
- Sponsor
- Samsung Medical Center
- Start
- Aug 2022
- Primary completion
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of choline alfoscerate in major depressive disorder (MDD), sponsored by Samsung Medical Center. Started Aug 2022; status: completed.
02
Drugs
choline alfoscerate
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT05257902.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05257902.